Biotechnology at Cabrini University

A debt-to-earnings ratio of 0.51 suggests manageable repayment—borrowers typically aim to keep student debt below their expected first-year salary. While Cabrini's figures come from peer institutions rather than its own graduates, that $24,125 in estimated debt against $47,000 in first-year earnings falls within reasonable bounds. However, the national median debt for biotechnology bachelor's programs sits at $20,618, meaning this estimate runs about $3,500 higher than typical. That difference matters when you're making monthly loan payments.

The bigger question mark is career trajectory. Biotechnology often serves as a stepping stone to graduate programs or specialized certifications, and first-year earnings don't tell the full story. Similar programs nationally cluster tightly around $47,000, with top performers reaching only $51,658—a relatively narrow range that suggests the field has consistent but modest entry-level compensation. For students planning to enter the workforce immediately after graduation, that starting salary needs to support both loan payments and living expenses in the Philadelphia area, where costs run higher than many regions.

Given the reliance on estimated figures and Cabrini's smaller biotechnology cohort, families should directly ask the school about graduate outcomes: Where do biotechnology alumni land their first jobs? What percentage continue to graduate school? Without program-specific data, you're betting on Cabrini matching national patterns—a reasonable assumption, but one worth verifying before committing.